|
|
ix | |
Preface |
|
xv | |
|
Section 1 Principles of cognitive neurorehabilitation |
|
|
1 | (118) |
|
Introduction to Section 1 |
|
|
3 | (3) |
|
1 Principles of neuroplasticity and behavior |
|
|
6 | (16) |
|
|
|
2 Principles of compensation in cognitive neuroscience and neurorehabilitation |
|
|
22 | (17) |
|
|
|
|
3 The patient as a moving target: the importance to rehabilitation of understanding variability |
|
|
39 | (23) |
|
|
|
4 Hormones and allostasis in brain disease and repair |
|
|
62 | (17) |
|
|
|
5 Principles in conducting rehabilitation research |
|
|
79 | (12) |
|
|
|
6 Outcome measurement in cognitive neurorehabilitation |
|
|
91 | (15) |
|
|
|
7 Principles in evaluating cognitive rehabilitation research |
|
|
106 | (13) |
|
|
Section 2 Application of imaging technologies |
|
|
119 | (82) |
|
Introduction to Section 2 |
|
|
121 | (3) |
|
8 Structural neuroimaging: defining the cerebral context for cognitive rehabilitation |
|
|
124 | (25) |
|
|
|
|
9 Functional neuroimaging and cognitive rehabilitation: healthy aging as a model of plasticity |
|
|
149 | (13) |
|
|
10 Functional brain imaging and neurological recovery |
|
|
162 | (20) |
|
|
11 The role of neuroelectric and neuromagnetic recordings in assessing learning and rehabilitation effects |
|
|
182 | (19) |
|
|
|
Section 3 Factors affecting successful outcome |
|
|
201 | (92) |
|
Introduction to Section 3 |
|
|
203 | (2) |
|
12 Mood, affect and motivation in rehabilitation |
|
|
205 | (13) |
|
|
|
13 Anosognosia and the process and outcome of neurorehabilitation |
|
|
218 | (14) |
|
|
14 Psychosocial considerations in cognitive rehabilitation |
|
|
232 | (18) |
|
|
|
15 Exercise, cognition and dementia |
|
|
250 | (22) |
|
|
|
16 Is there a role for diet in cognitive rehabilitation? |
|
|
272 | (21) |
|
|
|
Section 4 Pharmacologic and biological approaches |
|
|
293 | (102) |
|
Introduction to Section 4 |
|
|
295 | (3) |
|
17 Pharmacologic approaches to cognitive rehabilitation |
|
|
298 | (23) |
|
|
|
18 Pharmacologic treatment of cognitive impairment after traumatic brain injury |
|
|
321 | (13) |
|
|
19 Pharmacologic interventions for cognition in dementia |
|
|
334 | (14) |
|
|
|
20 Neurogenesis-based regeneration and cognitive therapy in the adult brain. Is it feasible? |
|
|
348 | (12) |
|
|
21 The impact of cerebral small vessel disease on cognitive impairment and rehabilitation |
|
|
360 | (16) |
|
|
|
22 Intrinsic and extrinsic neural stem cell treatment of central nervous system injury and disease |
|
|
376 | (19) |
|
|
|
|
Section 5 Behavioral/neuropsychological approaches |
|
|
395 | (168) |
|
Introduction to Section 5 |
|
|
397 | (4) |
|
23 The use of constraint-induced movement therapy (CI therapy) to promote motor recovery following stroke |
|
|
401 | (16) |
|
|
|
24 Effects of physical activity on cognition and brain |
|
|
417 | (18) |
|
|
|
|
|
435 | (14) |
|
|
|
|
|
|
|
26 Rehabilitation of neglect |
|
|
449 | (15) |
|
|
|
27 Rehabilitation of frontal lobe functions |
|
|
464 | (23) |
|
|
|
|
28 Executive functioning in children with traumatic brain injury in comparison to developmental ADHD |
|
|
487 | (20) |
|
|
|
29 Rehabilitation of attention following traumatic brain injury |
|
|
507 | (15) |
|
|
30 Memory rehabilitation for people with brain injury |
|
|
522 | (19) |
|
|
|
31 Memory rehabilitation in older adults |
|
|
541 | (22) |
|
|
|
|
563 | (12) |
|
32 The future of cognitive neurorehabilitation |
|
|
565 | (10) |
|
|
Index |
|
575 | |